Three Biotechs That Takeover: Top 2026 M&A Targets
As large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
Travel credit card points can significantly reduce your travel costs. Learn how to leverage their value for your next trip.
23,657 articlesAs large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
SpaceX’s IPO filing reveals Elon Musk’s proposed package, a historic grant that vests only if the company reaches a $...
Rigetti Computing stock surged as government funding boosted optimism for quantum tech. Learn what happened, what it ...
A large insider stake reduction coincided with Boise Cascade stock down, prompting questions about valuation and risk...
Zscaler is set to report Q3 after the close on May 28, 2026, with analysts eyeing ARR growth, AI monetization progres...
Snowflake beat estimates, raised its full-year outlook, and committed $6 billion to expand collaboration with AWS, se...
Get ahead of ARBE's Q1 2026 results with a practical framework. This guide breaks down what to watch in arbe (arbe) 2...
A 31-year-old faces a classic ROI test: borrow to earn more. With $58K already owed, the plan for an $80K online degr...
Interpreting the bbcp 2026 earnings transcript reveals how BBCP is growing, where margins are headed, and what to exp...
A recent SEC Form 4 shows a Teladoc executive sold roughly $71,000 worth of stock. This article breaks down what that...
SpaceX's planned IPO has drawn record demand, but market watchers warn buyers to scrutinize the order book for true d...
Tilray is expanding beyond its home market, but the stock market isn’t fully pricing in that growth. This article bre...